Emerald Health Therapeutics Quick Ratio (EMHTF) starting from the fourth quarter 2019 to fourth quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Emerald Health Therapeutics Inc.  (EMHTF)

Emerald Health Therapeutics's Quick Ratio

EMHTF's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2019, Quick Ratio deteriorated to 0.1 a new company low.

Within Major Pharmaceutical Preparations industry 474 other companies have achieved higher Quick Ratio than Emerald Health Therapeutics in fourth quarter 2019. While Quick Ratio total ranking has improved so far during the Q4 2019 to 4186, from total ranking in the third quarter 2019 at 4191.

Explain Quick Ratio?
How much Cash & cash equivalents EMHTF´s has?
What are EMHTF´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMHTF Quick Ratio (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 0
Q1		 (Dec 31 2018)
Q4
Y / Y Current Liabilities Change -28.98 % -28.98 % -28.98 % -28.98 % 516.41 %
Y / Y Cash & cash equivalent Change -92.99 % -92.99 % -92.99 % -92.99 % -22.38 %
Quick Ratio MRQ 0.1 0.1 0.1 0.1 1
EMHTF's Total Ranking # 4186 # 4191 # 4197 # 4230 # 1788
Seq. Current Liabilities Change 0 % 0 % 0 % -28.98 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -92.99 % 0 %



Quick Ratio fourth quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 475
Healthcare Sector # 891
Overall Market # 4186


Quick Ratio Statistics
High Average Low
1 0.55 0.1
(Dec 31 2018)   (Dec 31 2019)




Financial Statements
Emerald Health Therapeutics's Current Liabilities $ 20 Millions Visit EMHTF's Balance sheet
Emerald Health Therapeutics's Cash & cash equivalent $ 2 Millions Visit EMHTF's Balance sheet
Source of EMHTF's Sales Visit EMHTF's Sales by Geography


Cumulative Emerald Health Therapeutics's Quick Ratio

EMHTF's Quick Ratio for the trailling 12 Months

EMHTF Quick Ratio

 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 0
12 Months		 (Dec 31 2018)
12 Months
Y / Y Current Liabilities TTM Growth -28.98 % -1 % 58.19 % 219.23 % 2365.65 %
Y / Y Cash & cash equivalent TTM Growth -92.99 % -71.78 % -34.92 % 34.16 % 210.47 %
Quick Ratio TTM 0.1 0.39 0.62 0.82 1
Total Ranking TTM # 5147 # 1769 # 2063 # 4729 # 4710
Seq. Current Liabilities TTM Growth -9.26 % -8.47 % -7.81 % -7.25 % 26.49 %
Seq. Cash & cash equivalent TTM Growth -76.84 % -43.45 % -30.29 % -23.25 % -6.72 %

Quick ratio ranking by company, industry and sector >> Back to EMHTF Financial Strength Comparisons >> Go to Compare EMHTF Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in EMHTF's Current Liabilities to $19.68 millions, cumulative Quick Ratio to 0.1 below the EMHTF average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 478 other companies have achieved higher Quick Ratio than Emerald Health Therapeutics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2019 from 1769 to 5147.

Explain Quick Ratio?
How much Cash & cash equivalents EMHTF´s has?
What are EMHTF´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 479
Healthcare Sector # 939
Within the Market # 5147


trailing twelve months Quick Ratio Statistics
High Average Low
1 0.62 0.1
(Dec 31 2018)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2019, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
International Stem Cell Corporation  0.25 $ 0.484  Millions$ 1.913  Millions
Jaguar Health Inc   0.25 $ 3.883  Millions$ 15.392  Millions
Health right Discoveries Inc   0.25 $ 2.242  Millions$ 9.078  Millions
Zomedica Corp   0.24 $ 0.511  Millions$ 2.088  Millions
Assertio Holdings inc   0.23 $ 42.107  Millions$ 184.553  Millions
Intelgenx Technologies Corp   0.23 $ 1.912  Millions$ 8.447  Millions
Axim Biotechnologies Inc   0.21 $ 0.725  Millions$ 3.395  Millions
Cannapharmarx Inc   0.21 $ 1.310  Millions$ 6.215  Millions
Nls Pharmaceutics Ltd  0.21 $ 0.220  Millions$ 1.048  Millions
Earth Science Tech Inc   0.21 $ 0.128  Millions$ 0.618  Millions
Pfizer Inc  0.21 $ 8,941.000  Millions$ 43,455.000  Millions
Eli Lilly And Company  0.18 $ 2,452.800  Millions$ 13,723.200  Millions
Astrazeneca Plc  0.17 $ 5,369.000  Millions$ 31,801.000  Millions
Bioxytran Inc   0.17 $ 0.170  Millions$ 1.019  Millions
Provectus Biopharmaceuticals Inc   0.16 $ 0.591  Millions$ 3.587  Millions
Zyla Life Sciences  0.16 $ 11.965  Millions$ 75.771  Millions
Vtv Therapeutics Inc   0.15 $ 2.027  Millions$ 13.381  Millions
Geovax Labs Inc   0.15 $ 0.294  Millions$ 2.016  Millions
Akorn Inc  0.15 $ 144.804  Millions$ 993.234  Millions
Vivus Inc  0.15 $ 32.649  Millions$ 225.146  Millions
Viatris Inc   0.14 $ 517.900  Millions$ 3,683.100  Millions
Teva Pharmaceutical Industries Limited  0.13 $ 1,975.000  Millions$ 14,897.000  Millions
Iterum Therapeutics Plc  0.12 $ 4.801  Millions$ 39.247  Millions
China Pharma Holdings Inc  0.11 $ 1.075  Millions$ 10.045  Millions
The Greater Cannabis Company Inc   0.11 $ 0.025  Millions$ 0.232  Millions
Neuropathix Inc.  0.10 $ 0.139  Millions$ 1.327  Millions
Rapid Therapeutic Science Laboratories Inc   0.10 $ 0.125  Millions$ 1.216  Millions
Emerald Health Therapeutics Inc.  0.10 $ 1.934  Millions$ 19.676  Millions
Cytodyn inc   0.10 $ 2.613  Millions$ 26.926  Millions
Bespoke Extracts Inc  0.09 $ 0.010  Millions$ 0.111  Millions

Date modified: 2026-09-08T15:09:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.